Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$16,245,952
+$265,199 QoQ
Shares Held
63,968
-2.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#848
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SECURIAN ASSET MANAGEMENT, INC holds $78,680,706 across 9 Drug Manufacturers - General names. JNJ ranks #2 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,012 | $25,202,425 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
63,968 | $16,245,952 | |
| 3 | ABBV |
AbbVie Inc.
|
46,949 | $11,814,246 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,631 | $8,433,583 | |
| 5 | AMGN |
Amgen Inc
|
14,346 | $5,194,973 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
32,954 | $4,163,408 | |
| 7 | PFE |
Pfizer Inc
|
151,478 | $3,647,590 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
54,255 | $3,126,173 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,245,952 | 63,968 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $15,980,753 | 65,377 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $13,557,915 | 65,513 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $21,566,014 | 116,309 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $19,215,339 | 125,796 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $21,143,936 | 127,496 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $18,713,683 | 129,399 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $21,576,668 | 133,140 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,226,497 | 138,386 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $22,429,285 | 141,787 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $23,896,737 | 152,461 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $26,914,067 | 172,803 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $35,722,360 | 215,819 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $34,079,230 | 219,866 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $38,635,298 | 218,711 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $35,004,617 | 214,279 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $37,872,823 | 213,356 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $38,058,192 | 214,739 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $37,223,292 | 217,591 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $36,024,190 | 223,060 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $37,159,742 | 225,566 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $37,232,835 | 226,546 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $36,877,596 | 234,322 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $35,963,750 | 241,562 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $34,404,426 | 244,645 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $34,083,702 | 259,923 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||